A majority of patients with COVID-19 exhibit a predominant IL-1/IL-6 signature, but can evolve into an IL-18/IFNγ signature mimicking cytokine profiles observed in other inflammatory diseases such as macrophage activation syndrome (MAS) (8). This evidence concerns the gene IL1A and COVID-19.